Tag: drugs

Study: Preoperative dexmedetomidine stabilizes vitals in anxious GI cancer patients

Editor's Note Low-dose dexmedetomidine effectively stabilizes blood pressure and heart rate during key perioperative stages in gastrointestinal tumor patients with moderate to severe anxiety, according to a July 1 study published in BMC Psychiatry.   Researchers enrolled 100 patients undergoing elective laparoscopic gastrointestinal tumor resection. Anxiety levels were measured using…

Read More

By: Matt Danford
July 1, 2025
Share

Survey: Drug shortages impact hospital labor costs

Editor's Note Hospitals spent nearly $900 million in labor last year managing drug shortages, dedicating over 20 million hours to activities such as sourcing alternatives, updating systems, and communicating with care teams, according to a new Vizient survey published June 17. Conducted in late 2023 and detailed in Vizient’s June…

Read More

By: Matt Danford
June 24, 2025
Share

Study: Bariatric surgery leads to five times greater weight loss than GLP-1 drugs

Editor's Note Bariatric surgery produced five times greater weight loss than GLP-1 medications in a new study of over 51,000 patients with obesity, according to a June 18 article from Fox News. The retrospective study, funded by the NIH and conducted by researchers at NYU Langone Health and NYC Health…

Read More

By: Matt Danford
June 23, 2025
Share

New GLP-1 guidance urges longer fasting before anesthesia

Editor's Note Patients taking GLP-1 receptor agonists (GLP-1 RAs) do not need to discontinue these medications before undergoing anesthesia but should follow extended preoperative fasting protocols to reduce aspiration risk, according to a June 5 article in Medscape. As detailed in the article, this recommendation comes from a new multidisciplinary…

Read More

By: Matt Danford
June 17, 2025
Share

Painkiller without opioid risks shows potential in animal trials

Editor's Note An experimental compound developed at Duke University School of Medicine provides strong pain relief without the side effects or addiction potential of opioids, according to a May 19 announcement from the university. Known as SBI-810, the drug targets a specific receptor in the nervous system and uses a…

Read More

By: Matt Danford
June 3, 2025
Share

CMS takeover of 340B looms as some health systems double down on drug discount strategy

Editor's Note The federal 340B Drug Pricing Program may soon shift from the Health Resources and Services Administration (HRSA) to the Centers for Medicare and Medicaid Services (CMS), a move that could bring tighter oversight and lasting consequences for safety-net providers, Modern Healthcare June 2 reports. The proposed transfer, part…

Read More

By: Tarsilla Moura
June 3, 2025
Share

AI-powered smart glasses catch drug errors

Editor's Note An AI-powered wearable camera has achieved 99.6% accuracy in detecting potentially deadly drug mix-ups, including in the OR, NBC News reported May 25. Developed by Kelly Michaelsen, MD, at UW Medicine, the smart glasses scan medication labels in real time, alerting anesthesia providers to syringe-vial mismatches before drugs…

Read More

By: Matt Danford
May 30, 2025
Share

Clinicians urged to rethink gynecologic pain management

Editor's Note Pain among patients undergoing in-office gynecologic procedures is widely underestimated and ineffectively treated, particularly for those with trauma histories, chronic pain, or marginalized identities, according to a new Clinical Consensus from the American College of Obstetricians and Gynecologists. The report stresses that individualized, evidence-informed, and trauma-sensitive strategies are…

Read More

By: Matt Danford
May 23, 2025
Share

Study: Blocking stress-linked prolactin surge relieves postoperative pain in women

Editor's Note Blocking stress-induced prolactin may significantly reduce postoperative pain in women and curb the need for opioids, according to a study led by University of Arizona Health Sciences. News-Medical.Net summarized the findings May 20. Published in Proceedings of the National Academy of Sciences, the research suggests a path toward…

Read More

By: Matt Danford
May 21, 2025
Share

Study: SGLT2 inhibitors raise postop euglycemic ketoacidosis risk but lower mortality

Editor's Note Patients taking SGLT2 inhibitors face a higher risk of postoperative euglycemic ketoacidosis (eKA) but experience fewer acute kidney injuries and deaths after surgery, according to an April 30 article in Medical Xpress. The article focuses on new research published in JAMA Surgery. Led by researchers at the University…

Read More

By: Matt Danford
May 14, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat